Sprache: Englisch
Verlag: Cambridge University Press, 1995
ISBN 10: 0521495784 ISBN 13: 9780521495783
Anbieter: Alexander Books (ABAC/ILAB), Ancaster, ON, Kanada
Erstausgabe
Hardcover. Zustand: As New. 1st Edition. 458 Pages. Book.
Sprache: Englisch
Verlag: Cambridge University Press, 2005
ISBN 10: 0521499216 ISBN 13: 9780521499217
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 68,85
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 2005
ISBN 10: 0521499216 ISBN 13: 9780521499217
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 100,46
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Brings together basic aspects of the regulation of MHC antigens with important clinical applications. Editor(s): Blair, G. Eric; Pringle, Craig R. (University of Warwick); Maudsley, D. John (University of Warwick). Num Pages: 460 pages, 47 b/w illus. 22 tables. BIC Classification: PSC. Category: (P) Professional & Vocational. Dimension: 228 x 152 x 24. Weight in Grams: 640. . 2008. 1st Edition. paperback. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Cambridge University Press, 2005
ISBN 10: 0521499216 ISBN 13: 9780521499217
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The major histocompatibility complex (MHC) genes are involved in the immune system's response to tumour and infected cells and in generating an immune response. This book brings together basic aspects of the regulation of MHC antigens with important clinical applications (in viral infection, viral oncology, cancer biology and autoimmunity). There is a strong emphasis on situations where MHC expression is modulated (either stimulated or repressed). The book's major themes are: the mechanisms of MHC expression explored at several levels including the transcription and translation of MHC genes and the insertion of MHC protein molecules into plasma membranes; the effect of cytokines on MHC expression both in the aetiology of certain diseases and in possible immunotherapeutic approaches to disease; and the use of gene therapy to modify MHC expression in cancer cells, and thereby cause tumour rejection.